Oxford Nanopore Technologies
John Schoellerman joined Oxford Nanopore in July 2019 as SVP, Corporate Development and Investment. John joined from Lazard, where he had been Managing Director and head of Medtech, leading a broad range of strategic transactions for clients in US, Europe and Asia. Previously, John worked in healthcare investment banking at J.P. Morgan in San Francisco, London and New York. John holds a B.A. from Harvard and an M.B.A. from INSEAD.
This person is not in any offices
Oxford Nanopore Technologies
9 followers
Our goal is to enable the analysis of any living thing, by any person, in any environment. Explore our scalable DNA sequencing products and services including the portable MinION and powerful PromethION.